These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 3856974)

  • 1. [The antibacterial activity of ceftriaxone and evaluation criteria for an agar diffusion test with ceftriaxone].
    Grimm H
    Wien Med Wochenschr Suppl; 1985; 87():3-8. PubMed ID: 3856974
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
    Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interpretation criteria for sensitivity testing of ceftriaxone in agar diffusion test according to the DIN 58940 method.
    Grimm H
    Chemotherapy; 1984; 30(1):49-53. PubMed ID: 6319090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative experimental antibacterial activity of ceftriaxone (Ro 13-9904).
    Böhni E
    Chemioterapia; 1984 Feb; 3(1):25-32. PubMed ID: 6100173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of ceftriaxone: a review.
    Cleeland R; Squires E
    Am J Med; 1984 Oct; 77(4C):3-11. PubMed ID: 6093515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftriaxone against gram-negative and gram-positive bacteria: bactericidal and post-antibiotic effect.
    Ravizzola G; Bonfanti C; Savoldi E; Turano A
    Chemioterapia; 1985 Jun; 4(3):204-8. PubMed ID: 3875430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sensitivity to cefotiam of 494 hospital bacterial strains. Determination of minimal inhibitory concentration and comparison with other beta-lactams].
    Reynaud A; Desnoes M; Derriennic M; Courtieu AL
    Pathol Biol (Paris); 1985 May; 33(5):313-9. PubMed ID: 3929216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cefotaxime, moxalactam and ceftriaxone: comparison of in vitro activity against hospital strains of Enterobacteriaceae belonging to the 4 principal phenotypes of sensitivity to beta-lactams].
    Jarlier V; Bismuth R; Grosset J
    Pathol Biol (Paris); 1983 May; 31(5):336-42. PubMed ID: 6312393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftriaxone: a three centre comparative in vitro susceptibility study.
    Emmerson AM; Lamport PA; Reeves DS; Bywater MJ; Holt HA; Wise R; Andrews J; Hall MJ
    Eur J Clin Microbiol; 1985 Apr; 4(2):142-4. PubMed ID: 4006933
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
    Baumgärtner M; Grehn M; Wundt W
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial activity of ceftriaxone, cefotaxime, desacetylcefotaxime, and cefotaxime-desacetylcefotaxime in the presence of human serum.
    Jones RN; Barry AL
    Antimicrob Agents Chemother; 1987 May; 31(5):818-20. PubMed ID: 3606081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activity of cefotaxime and ceftriaxone and of imipenem, pefloxacin and norfloxacin on 13 species of bacteria].
    Rahal K
    Arch Inst Pasteur Alger; 1989; 57():213-48. PubMed ID: 2489401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of susceptibilities of anaerobic bacteria to cefmenoxime, ceftriaxone, and other antimicrobial compounds.
    Pollock HM; Holt J; Murray C
    Antimicrob Agents Chemother; 1983 May; 23(5):780-3. PubMed ID: 6307137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term administration of ceftriaxone (Ro 13-9904) to complicated urinary tract infections].
    Oishi K; Kawakita M; Hida S; Higashi Y; Yamauchi T; Yoshida O
    Hinyokika Kiyo; 1985 Apr; 31(4):711-21. PubMed ID: 4036746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpretation of susceptibility testing of ceftriaxone.
    Squires E; Cleeland R; Christenson J; Boehni E
    Am J Med; 1984 Oct; 77(4C):12-6. PubMed ID: 6093512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of antibiotic disk charge on concordance curve of cefotaxime ].
    Drugeon HB; Seon M; Reynaud A; Chung SS; Courtieu AL
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):517-21. PubMed ID: 6289229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative evaluation of the antibacterial activity of cefotaxime and cephalotin by using an automated antimicrobial susceptibility determination system].
    Concia E; Marone P; Dos Santos C; Bono L
    Quad Sclavo Diagn; 1982 Jun; 18(2):223-32. PubMed ID: 6300953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of protein binding on the antibacterial effects of 2 cephalosporins].
    Meinardi G; Grasso S; de Carneri I
    G Ital Chemioter; 1985; 32(2):343-6. PubMed ID: 3869113
    [No Abstract]   [Full Text] [Related]  

  • 20. [In vitro activity of cefatiolene (RP 42,980) against hospital bacteria. Comparison with cefotaxime and lamoxactam. Results of a multicenter study].
    Duval J; Soussy CJ; Deforges L; Le Van Thoi J; Acar JF; Kitzis D; Dabernat H; Christol D; Bure A; Courtieu AL
    Pathol Biol (Paris); 1983 May; 31(5):357-61. PubMed ID: 6312397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.